VANABIN2 Antibody

What is Vanabin2 and why would I need an antibody against it?

Vanabin2 is a vanadium-binding protein first identified in the vanadium-rich ascidian Ascidia sydneiensis samea. It possesses a novel bow-shaped conformation with four alpha-helices connected by nine disulfide bonds . The protein functions as a V(V)-reductase, capable of reducing V(V) to V(IV) .

Methodologically, VANABIN2 antibodies enable:

• Immunolocalization of Vanabin2 in ascidian tissues and blood cells

• Analysis of Vanabin2 expression patterns across different tissues

• Immunoprecipitation studies to identify protein-protein interactions

• Quantitative assessment of Vanabin2's role in vanadium accumulation mechanisms

How specific is the VANABIN2 antibody considering the multiple Vanabin variants?

This represents a critical methodological consideration as multiple Vanabin variants exist, including Vanabins 1-4, VanabinP, and sequence variants of Vanabin2 (such as 14MT) . When designing experiments, researchers should:

• Validate antibody specificity against all known Vanabin family members through Western blot analysis

• Consider that while the 18 cysteine residues are conserved across variants, sequences can vary at up to 14 specific positions while maintaining metal-binding capabilities

• Test for cross-reactivity with related proteins like VanabinX, which contains a unique acidic amino acid-rich C-terminal domain

• Implement peptide competition assays using synthetic peptides corresponding to the immunizing epitope

What sample preparation methods optimize VANABIN2 antibody performance?

Optimal sample preparation enhances detection sensitivity and specificity:

• Fixation protocols:

  • Use 4% paraformaldehyde for immunohistochemistry of ascidian tissues

  • Avoid harsh fixatives that might disrupt the nine disulfide bonds critical to Vanabin2's structure

• Protein extraction considerations:

  • Include metal chelators (EDTA/EGTA) in extraction buffers to prevent metal-induced conformational changes

  • Add protease inhibitors to prevent degradation of the ~15 kDa Vanabin2 protein

  • Consider both reducing and non-reducing conditions depending on the epitope recognized

• Blood cell isolation:

  • Implement density gradient centrifugation to isolate vanadocytes (vanadium-accumulating blood cells)

  • Process samples quickly to prevent ex vivo changes in metal distribution

How can I use VANABIN2 antibody to investigate the vanadium reduction pathway?

A systematic approach using VANABIN2 antibody can reveal the molecular mechanisms of the vanadium reduction pathway:

• Co-immunoprecipitation strategy:

  • Use VANABIN2 antibody to pull down Vanabin2 and associated proteins

  • Identify enzymes of the pentose phosphate pathway that produce NADPH required for reduction

  • Analyze the precipitate for Vanabin-interacting protein 1 (VIP1), which localizes to the cytoplasm of signet ring cells and giant cells

• Immunodepletion approach:

  • Systematically deplete Vanabin2 from cell lysates using the antibody

  • Measure remaining V(V) reductase activity to quantify Vanabin2's contribution

  • Compare results with the known reduction rate of 0.170 μM per micromolar protein within 30 minutes

• Spatial organization mapping:

  • Employ immunoelectron microscopy with gold-labeled VANABIN2 antibody

  • Correlate Vanabin2 localization with vanadium-rich compartments

  • Investigate the role of the C-terminal acidic domain, which enhances V reduction by Vanabin2 to 1.3-fold and of VanabinX itself to 1.7-fold in trans mode

What are the considerations when using VANABIN2 antibody in metal ion affinity studies?

Metal ion interactions introduce specific methodological challenges:

• Epitope accessibility issues:

  • Metal binding may alter Vanabin2 conformation, potentially masking antibody epitopes

  • HSQC perturbation experiments indicate that vanadyl cations coordinate with amine nitrogens and localize on the same face of the Vanabin2 molecule

  • Design control experiments with and without metal ions to assess binding efficiency

• Metal/antibody competition:

  • If the antibody recognizes a metal-binding region, direct competition may occur

  • Copper(II) ions are known to inhibit vanadium(IV) binding to vanabins in vitro

  • Develop a workflow where antibody detection precedes metal binding studies

• Metal specificity considerations:

  • Account for Vanabin2's differential affinity for various metal ions (Cu(II) > Zn(II) > Co(II))

  • Consider that Vanabin2 variants like 14MT show the same metal-ion selectivity but different affinity for VO(2+)

  • Design experiments to distinguish between metal-bound and metal-free forms

How should I design controls for immunoprecipitation experiments using VANABIN2 antibody?

Robust control design ensures reliable immunoprecipitation results:

• Essential negative controls:

  • Isotype control: Use an irrelevant antibody of the same isotype

  • No-antibody control: Perform the procedure without any antibody

  • Blocking peptide control: Pre-incubate VANABIN2 antibody with immunizing peptide

• Positive controls:

  • Recombinant Vanabin2 protein spiked into non-expressing samples

  • Blood cell lysates, where Vanabin2 is known to be prominently expressed

• Validation approaches:

  • Reciprocal immunoprecipitation using antibodies against known interacting partners like VIP1

  • Mass spectrometry verification of precipitated proteins

  • Western blot quantification of Vanabin2 depletion efficiency

• Experimental variations:

  • Include conditions with and without metal ions (vanadium, copper)

  • Test both reducing and non-reducing conditions to assess disulfide bond importance

  • Vary pH to reflect the physiological environment of vanadocytes

What are the optimal conditions for Western blotting with VANABIN2 antibody?

Optimizing Western blot protocols for VANABIN2 antibody requires:

• Sample preparation:

  • Include metal chelators (EDTA/EGTA) to prevent metal-induced conformational changes

  • Add reducing agents only if the epitope is not dependent on disulfide bonds

  • Consider that Vanabin2 contains nine disulfide bonds that may affect migration

• Gel electrophoresis parameters:

  • Use 12-15% SDS-PAGE for the ~15 kDa Vanabin2 protein

  • Include recombinant Vanabin2 as a positive control

  • Consider running duplicate gels under reducing and non-reducing conditions

• Detection optimization:

  • Titrate antibody concentration (starting range: 1:500 to 1:2000)

  • Test both BSA and non-fat milk as blocking agents

  • Implement enhanced chemiluminescence for maximum sensitivity

• Data interpretation:

  • Be aware that sequence variants of Vanabin2 may show slight mobility differences

  • Validate bands using recombinant protein controls

  • Consider that interaction with other proteins like VIP1 may affect migration

How can I develop a quantitative ELISA using VANABIN2 antibody?

Developing a quantitative ELISA requires systematic optimization:

• Assay format selection:

  • Direct ELISA: Immobilize sample directly, detect with VANABIN2 antibody

  • Sandwich ELISA: Capture with one VANABIN2 antibody clone, detect with another

  • Competitive ELISA: Compete sample Vanabin2 with standardized Vanabin2-enzyme conjugate

• Protocol optimization:

  • Test different coating buffers (carbonate buffer pH 9.6 vs. PBS pH 7.4)

  • Titrate antibody concentration to determine optimal working dilution

  • Optimize incubation times and temperatures

• Standard curve preparation:

  • Use purified recombinant Vanabin2 at concentrations of 0.1-100 ng/mL

  • Prepare matrix-matched standards to account for sample composition effects

• Vanabin2-specific considerations:

  • Include EDTA in buffers to prevent metal-induced conformational changes

  • Verify specificity against other Vanabin family members

  • Account for potential variations in Vanabin2 sequence in different ascidian populations

How can I optimize immunohistochemistry protocols with VANABIN2 antibody?

Systematic optimization of immunohistochemistry requires:

• Fixation evaluation:

  • Compare paraformaldehyde and glutaraldehyde fixatives

  • Test fixation times (4-24 hours) and temperatures

  • Consider specialized fixation for ascidian tissues with high vanadium content

• Antigen retrieval methods:

  • Test heat-induced epitope retrieval with citrate (pH 6.0) and EDTA (pH 9.0) buffers

  • Evaluate enzymatic retrieval with proteinase K or trypsin

  • Determine if retrieval affects metal distribution in tissues

• Antibody parameters:

  • Test VANABIN2 antibody at multiple dilutions (1:50-1:1000)

  • Compare overnight 4°C incubation versus 1-2 hours at room temperature

  • Evaluate signal amplification systems for detecting low abundance signals

• Ascidian-specific considerations:

  • Implement counterstaining to visualize tissue architecture

  • Include appropriate controls (positive tissue, negative controls, blocking peptide)

  • Address potential background from endogenous peroxidase activity in blood cells

How should I validate VANABIN2 antibody specificity in my experimental system?

Comprehensive validation ensures reliable results:

• Multiple detection methods:

  • Western blot: Confirm single band of expected molecular weight

  • Immunoprecipitation: Verify Vanabin2 enrichment by mass spectrometry

  • Immunocytochemistry: Compare staining pattern with known localization in blood cells

• Controls:

  • Positive: Recombinant Vanabin2, blood cell lysates

  • Negative: Tissues lacking Vanabin2 expression

  • Competitive inhibition: Pre-incubate with immunizing peptide

• Cross-reactivity assessment:

  • Test against other Vanabin family members (Vanabins 1, 3, 4, VanabinP)

  • Evaluate against Vanabin2 variants like 14MT

  • Consider testing in heterologous expression systems

How do I interpret contradictory results between VANABIN2 antibody signals and mRNA expression data?

Discrepancies between protein and mRNA levels require systematic investigation:

• Biological explanations:

  • Post-transcriptional regulation mechanisms

  • Protein trafficking between tissues (Vanabin2 is expressed in multiple tissues)

  • Variation in protein half-life across different cellular contexts

• Technical considerations:

  • Sensitivity differences between antibody detection and RT-PCR

  • Epitope masking in certain cellular compartments

  • Sample preparation artifacts affecting antibody accessibility

• Reconciliation approaches:

  • Perform time-course studies to detect temporal differences

  • Conduct cell-type specific analyses to resolve heterogeneity

  • Implement absolute quantification of both mRNA and protein

• Validation experiments:

  • Combined in situ hybridization and immunohistochemistry

  • Polysome profiling to assess translational status

  • Protein half-life determination via pulse-chase experiments

How can I use VANABIN2 antibody to investigate post-translational modifications?

Post-translational modifications may regulate Vanabin2 function:

• Detection strategies:

  • Immunoprecipitation with VANABIN2 antibody followed by mass spectrometry

  • Western blotting with modification-specific antibodies after immunoprecipitation

  • 2D gel electrophoresis to separate modified forms followed by immunoblotting

• Potential modifications:

  • Phosphorylation: May regulate metal-binding affinity

  • Redox modifications: Relevant given Vanabin2's role in V(V) reduction

  • Metal-induced conformational changes: Not strictly PTMs but affect protein function

• Experimental approaches:

  • Phosphatase treatment: Compare migration patterns before/after treatment

  • Redox manipulation: Examine Vanabin2 under oxidizing/reducing conditions

  • Site-directed mutagenesis: Mutate potential modification sites

How can VANABIN2 antibody help characterize the role of the acidic C-terminal domain in vanadium reduction?

The recent discovery of VanabinX with its unique acidic amino acid-rich C-terminal domain enables new research directions:

• Comparative analysis approach:

  • Use VANABIN2 antibody to immunoprecipitate different Vanabin variants

  • Compare V(V) reduction activity of immunoprecipitated proteins

  • Quantify the enhancement effect of the C-terminal domain, which increases V reduction by Vanabin2 to 1.3-fold and of VanabinX itself to 1.7-fold in trans mode

• Domain interaction studies:

  • Develop domain-specific antibodies targeting the acidic C-terminal region

  • Investigate whether the domain acts directly or through protein-protein interactions

  • Compare results with the known NADPH-coupled V(V)-reductase assay data

• Structure-function analysis:

  • Correlate antibody epitope accessibility with functional states

  • Investigate conformational changes induced by the acidic domain

  • Study the relationship between metal binding and reductase activity

How can I use VANABIN2 antibody to explore the interaction network between Vanabins and VIP1?

Mapping the Vanabin interaction network reveals functional relationships:

• Comprehensive interaction mapping:

  • Use VANABIN2 antibody for co-immunoprecipitation followed by mass spectrometry

  • Validate interactions with VIP1, which is localized in the cytoplasm of signet ring cells and giant cells

  • Investigate why VIP1 interacts with Vanabins 1, 2, 3, and 4 but not with Vanabin P

• Domain-specific interactions:

  • Determine which domains mediate Vanabin2-VIP1 interaction

  • Investigate the importance of the N-terminal domain of VIP1, which is crucial for interaction

  • Study how these interactions contribute to vanadium accumulation

• Metal influence on interactions:

  • Assess how metal binding affects Vanabin2-VIP1 interaction

  • Compare interaction strength under different redox conditions

  • Determine if VIP1 and Vanabin1 act as metal chaperones in vanadocytes

Can VANABIN2 antibody be used to develop biosensors for environmental monitoring?

Translating research findings into practical applications:

• Sensor platform development:

  • Immobilize VANABIN2 antibody on transducer surfaces

  • Detect conformational changes upon vanadium binding

  • Leverage the differential metal affinities of Vanabin2 for selective detection

• Detection mechanism:

  • Utilize Vanabin2's ability to reduce V(V) to V(IV) at a rate of 0.170 μM per micromolar protein

  • Implement colorimetric or electrochemical detection of the reduction process

  • Design competitive assays based on metal binding properties

• Sensitivity enhancement:

  • Incorporate signal amplification using nanomaterials

  • Exploit the high metal ion affinity of Vanabin2 variants

  • Design systems that mimic the natural metal accumulation properties of ascidians